SHELBY MASSETT: Open Payments
NPI 1508063413 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,887 in 123 payments from 12 companies in 2025. Trend: 2023 $2,307 · 2024 $2,109 · 2025 $1,887
Food & beverage: $1,877Education: $10
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $326 |
| GENZYME CORPORATION | 10 | $268 |
| ABBVIE INC. | 22 | $251 |
| UCB, Inc. | 21 | $241 |
| Novartis Pharmaceuticals Corporation | 21 | $230 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 15 | $179 |
| Incyte Corporation | 4 | $103 |
| Organon LLC | 8 | $93 |
| PFIZER INC. | 5 | $84 |
| Amgen Inc. | 2 | $48 |
Products named: TREMFYA, DUPIXENT, Bimzelx, COSENTYX, SKYRIZI, ILUMYA, OPZELURA, CIBINQO.
Industry payments across NY — which companies pay providers there.
